Vascular Innovations Webinars

We’re excited to announce two Industry-led webinars, hosted by the SVS Foundation, that will convene leading experts from Boston Scientific and Laminate to present the latest evidence, case-based discussions and real-world insights shaping vascular access and endovascular care.

Wednesday, October 29 | 6:00 PM Central Time

From Data to Decisions: Optimizing Outcomes in PAD & CLI with Eluvia DES
Presented by Boston Scientific

Join us for an engaging webinar designed for vascular surgeons navigating the complexities of endovascular PAD and CLI interventions.

This session will highlight the latest clinical evidence on the Eluvia Drug-Eluting Stent (DES), including insights from the SPORTS RCT, Eluvia Pooled Meta-Analysis, and Eluvia TRUE-PTX data. Faculty experts will discuss how these findings reinforce Eluvia’s advantages over alternative modalities—particularly in treating long, challenging lesions.

Through case-based discussions and interactive dialogue, participants will gain practical strategies for integrating DES therapy into real-world practice and comparing its role to DCB and BMS approaches.

Key topics include:

  • Clinical data reinforcing Eluvia DES effectiveness
  • Case insights on long, complex lesions
  • DES vs. DCB/BMS in decision-making
  • Real-world outcomes: reduced amputations and re-hospitalizations
  • Impact on patient quality of life and hospital economics

Don’t miss this opportunity to deepen your knowledge and explore how DES therapy can improve outcomes for patients with PAD and CLI.

Speakers: Dr. Anahita Dua, Massachusetts General Hospital, Dr. Sonya Noor, Buffalo General Medical Center, and Dr. Peter Schneider University of California, San Francisco

 

Register Now

 

Wednesday, November 12 | 6:00 PM Central Time

End Stage Kidney Disease & Vascular Access: “Innovation & Improved Fistula Outcome"
Presented by Laminate

Join us for a clinically focused webinar designed for vascular specialists seeking strategies to improve fistula outcomes in patients with end-stage kidney disease (ESKD).

Program Highlights

  • Dr. Keith Ozaki will open with a discussion on the hemodynamic and mechanical factors driving fistula failure, their impact on outcomes, and how VasQ’s unique extravascular support mechanism addresses these challenges.
  • Dr. Ellen Dillavou will review the extensive clinical evidence behind VasQ, including insights from 15 peer-reviewed publications and her personal clinical experience with the device.
  • Dr. John Lucas will share his real-world perspective, focusing on basilic vein transpositions and how VasQ integration has improved patient outcomes in his ESKD practice.

What to Expect

  • 30-minute presentation with expert-led discussions
  • 15 minutes of Q&A to address your questions
  • Interactive participant survey

Discover how VasQ is reshaping fistula care and delivering meaningful results for patients with ESKD.

Speakers: Dr. Keith Ozaki, Dr. Ellen Dillavou, Dr. John Lucas

 

Register Now